로딩 중…
지수 로딩 중…
Legend Biotech Corporation
LEGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$27.93-16.68%
2026-06-18
Price Chart
Legend Biotech Corporation-19.95%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.19B |
| Revenue | $1.14B |
| Net Income | $-250M |
| Total Assets | $1.60B |
| Net Assets | $968M |
| Value | |
| P/B | 5.36x |
| P/S | 4.56x |
| FCF Yield | -4.56% |
| Profitability | |
| ROE | -25.85% |
| ROA | -15.67% |
| Op. Margin | -11.92% |
| Revenue Growth | 56.42% |
| Financial Health | |
| Debt Ratio | 65.00% |
| Total Debt | $389M |
| FCF | $-236M |
| Cash | $646M |
| Current Ratio | 2.13x |
| Performance | |
| 1Y Return | -19.95% |
| 1M Return | 3.67% |
| From 52W High | -38.34% |
| 1Y MDD | -62.43% |
| Trading | |
| Volume | 13,088,858 shares |
| Trading Value | $372M |
| Per Share | |
| EPS | $-1.61 |
| BPS | $5.42 |